To clarify the controversy regarding the benefits of long-term oral digoxin in the treatment of heart failure, we evaluated hemodynamics at rest and during exercise in nine patients in sinus rhythm with symptomatic heart failure. Patients were studied during long-term digoxin therapy, after withdrawal of the drug, and six hours after readministration. Upon withdrawal of digoxin, pulmonary capillary-wedge pressure increased from 21 +/- 8 to 29 +/- 10 mm Hg, and cardiac index decreased from 2.4 +/- 0.7 to 2.1 +/- 0.6 liters per minute per square meter of body-surface area, suggesting a deterioration in left ventricular function. In addition, heart rate tended to increase and stroke-work index, stroke-volume index, and radioangiographic ejection fraction decreased. Acute readministration restored the hemodynamic values to those observed during long-term digoxin therapy. The improvement in hemodynamics during long-term digoxin administration was also observed during exercise. This improvement demonstrated the value of long-term oral digoxin therapy in congestive heart failure.
This article has been cited by other articles:
Gheorghiade, M., Adams, K. F. Jr, Colucci, W. S.
(2004). Digoxin in the Management of Cardiovascular Disorders. Circulation
109: 2959-2964
[Full Text]
Kjeldsen, K, Norgaard, A, Gheorghiade, M
(2002). Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure. Cardiovasc Res
55: 710-713
[Abstract][Full Text]
Clark, L. L.
(2000). Perioperative Treatment of Congestive Heart Failure. SEMIN CARDIOTHORAC VASC ANESTH
4: 223-235
[Abstract]
Wright, D J, Tan, L B
(1999). Classic techniques in medicine: The role of exercise testing in the evaluation and management of heart failure. Postgrad. Med. J.
75: 453-458
[Abstract][Full Text]
Abraham, W. T.
(1998). Pharmacologic Management of Chronic Heart Failure: A Review. SEMIN CARDIOTHORAC VASC ANESTH
2: 168-190
[Abstract]
COMMITTEE MEMBERS, , WILLIAMS, J. F. Jr, BRISTOW, M. R., FOWLER, M. B., FRANCIS, G. S., GARSON, A. Jr, GERSH, B. J., HAMMER, D. F., HLATKY, M. A., LEIER, C. V., PACKER, M., PITT, B., ULLYOT, D. J., WEXLER, L. F., WINTERS, W. L. Jr, TASK FORCE MEMBERS, , RITCHIE, J. L., CHEITLIN, M. D., EAGLE, K. A., GARDNER, T. J., GARSON, A. Jr, GIBBONS, R. J., LEWIS, R. P., O'ROURKE, R. A., RYAN, T. J.
(1995). Guidelines for the Evaluation and Management of Heart Failure : Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation
92: 2764-2784
[Full Text]
Gheorghiade, M., B. Hall, V., Jacobsen, G., Alam, M., Rosman, H., Goldstein, S.
(1995). Effects of Increasing Maintenance Dose of Digoxin on Left Ventricular Function and Neurohormones in Patients With Chronic Heart Failure Treated With Diuretics and Angiotensin-Converting Enzyme Inhibitors. Circulation
92: 1801-1807
[Abstract][Full Text]
Smith, T. W.
(1993). Digoxin in Heart Failure. NEJM
329: 51-53
[Full Text]